Philadelphia, PA, United States of America

Optofluidics Inc.


USPTO Granted Patents = 9

Forward Citations = 3

Loading Chart...
Loading Chart...

13 inventors (with patents filed for the assignee):

goldMedal Robert Hart (8 out of 9 patents)

silverMedal Colby Ashcroft (8 out of 8 patents)

bronzeMedal Brian DiPaolo (8 out of 8 patents)

4.  Thomas Castner (6 out of 6 patents)

5.  Bernardo Cordovez (5 out of 5 patents)

6.  Nathan Wall (4 out of 4 patents)

7.  Gjergji Konica (4 out of 4 patents)

8.  David Erickson (2 out of 26 patents)

9.  Alexey Aprelev (2 out of 2 patents)

10.  Christopher Earhart (2 out of 2 patents)

11.  Spencer Borg (1 out of 1 patent)

12.  Adam Ross (1 out of 1 patent)

13.  Paul Dyer (1 out of 1 patent)


9 patents:

Company Overview
Optofluidics Inc. specializes in the development and commercialization of innovative optofluidic technologies for use in a variety of applications including biomedical research, diagnostics, and environmental monitoring. The company's products leverage the unique capabilities of combining optics and fluidics to enable novel solutions for complex challenges. With a focus on precision, sensitivity, and scalability, Optofluidics Inc. is at the forefront of driving advancements in the field of optofluidics.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

9 Patents

#107 in Philadelphia, PA

#1,189 in Pennsylvania

#32,605 in US

Philadelphia, PA (US)
Philadelphia, PA, United States of America
Forward Citations = 3

13 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Optofluidics Inc.. Retrieved from https://idiyas.com/company/optofluidics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…